Quick Answer
ABBOTT LABORATORIES reported Revenue From Contract With Customer Excluding Assessed Tax of $44.33 billion for the year ending 2025.
- ABBOTT LABORATORIES showed an increase of +5.7% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from ABBOTT LABORATORIES's annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), ABBOTT LABORATORIES's Revenue From Contract With Customer Excluding Assessed Tax has grown by 112.6%.
- Historical annual values: Fiscal year 2025: $44.33 billion | Fiscal year 2024: $41.95 billion | Fiscal year 2023: $40.11 billion | Fiscal year 2022: $43.65 billion | Fiscal year 2021: $43.08 billion | Fiscal year 2020: $34.61 billion | Fiscal year 2019: $31.90 billion | Fiscal year 2018: $30.58 billion | Fiscal year 2017: $27.39 billion | Fiscal year 2016: $20.85 billion.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: